Antiviral

Revolade 50® Eltrombopag Tablets
Eltrombopag 50mg
- Composition
- Eltrombopag 50mg
- Dosage form
- Tablet
- Pack size
- Strip of 7 Tablet
- Manufacturer
- Novartis
- Also known as
- -
Supplied against a valid prescription where required, in line with the regulations of the destination country.
Revolade 50 mg contains eltrombopag and is used to treat low platelet counts in selected patients with chronic ITP, severe aplastic anaemia and certain cases of chronic hepatitis C-associated thrombocytopenia. It works by stimulating the thrombopoietin receptor, helping the bone marrow produce more platelets.
As prescribed by a doctor. Dose and duration depend on the condition being treated and the patient. Do not change the dose without medical advice.
Side effects vary by patient. Common and serious side effects are listed in the pack insert. Contact a doctor if you have severe or unexpected symptoms.
Tell your doctor about other medicines you take, allergies, pregnancy or breastfeeding, and any liver or kidney conditions before use.
Store below 30 °C in a dry place, in the original pack, out of reach of children.
Need product documents?
Ask for the pack insert, batch details or a COA with your quote.
Ask on WhatsApp →Related products
Antiviral
Antiviral
Antiviral
Antiviral
